Latest News & Features
Americas
Generics giant’s petition cites the cost of medicine and first-principles of innovation. 14 July 2022
Americas
New lawsuit comes months after the pair were accused of infringing lipid nanoparticle technology. 14 July 2022
Americas
A Delaware court found in favour of the AI company, which Microsoft bought for $16 billion last year. 12 July 2022
Americas
The dispute over a patent covering a blood glucose level monitor ends with a multimillion-dollar payment and a licence agreement. 12 July 2022
Americas
A major generic pharma company has failed to undo patents related to the oral suspension Quillivant XR. 8 July 2022
Big Pharma
The US Patent and Trademark Office and Food and Drug Administration have partnered to facilitate access to affordable drugs. 7 July 2022
Big Pharma
Germany-based CureVac has accused BioNTech of infringing four patents related to messenger ribonucleic acid technology. 7 July 2022
Americas
Licensing partners aim to prevent the introduction of a proposed eye drop generic treatment before the expiration of four patents. 5 July 2022
Big Pharma
The ruling marks the latest development of a long-running dispute over the alleged delay of a generic version of the blockbuster painkiller. 5 July 2022
article
The dispute centres on a process for extracting CBD from cannabis plant material, which anticipates the use of CBD as an anti-epileptic treatment. 5 July 2022